Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hull

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Plos One|December 4, 2015
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?Viviane D Lima, Ignacio Rozada, Jason Grebely, et al.
Substance Abuse Treatment, Prevention, and Policy|December 14, 2021
Perceived difficulty of getting help to reduce or abstain from substances among sexual and gender minority men who have sex with men (SGMSM) and use methamphetamine during the early period of the COVID-19 pandemicKiffer Card, Madison McGuire, Jordan Bond-Gorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?Nadine Kronfli, Jim Young, Shouao Wang, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Open Forum Infectious Diseases|May 25, 2026
Successful Scale-up of Syphilis Testing Linked to Routine HIV Viral Load Monitoring in British ColumbiaKyle A Thompson, Matthew Clifford-Rashotte, Wendy Zhang, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
Plos Medicine|December 9, 2025
Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation studyAngela McLaughlin, Junine Toy, Vincent Montoya, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
BMC Public Health|June 13, 2023
Disjuncture between self-perceived and clinically assessed risk of HIV among gay, bisexual, and other men who have sex with men in Ontario and British Columbia, CanadaOscar Javier Pico-Espinosa, Mark Hull, Mark Gaspar, et al.
Lancet Regional Health. Americas|April 9, 2024
Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling studyJielin Zhu, Bronhilda T Takeh, Jummy David, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Plos One|December 4, 2015
Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?Viviane D Lima, Ignacio Rozada, Jason Grebely, et al.
Substance Abuse Treatment, Prevention, and Policy|December 14, 2021
Perceived difficulty of getting help to reduce or abstain from substances among sexual and gender minority men who have sex with men (SGMSM) and use methamphetamine during the early period of the COVID-19 pandemicKiffer Card, Madison McGuire, Jordan Bond-Gorr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?Nadine Kronfli, Jim Young, Shouao Wang, et al.
The International Journal on Drug Policy|March 9, 2023
The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national eliminationJim Young, Shouao Wang, Charlotte Lanièce Delaunay, et al.
Open Forum Infectious Diseases|May 25, 2026
Successful Scale-up of Syphilis Testing Linked to Routine HIV Viral Load Monitoring in British ColumbiaKyle A Thompson, Matthew Clifford-Rashotte, Wendy Zhang, et al.
Journal of Viral Hepatitis|August 25, 2018
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individualsSahar Saeed, Erica E M Moodie, Erin Strumpf, et al.
Plos Medicine|December 9, 2025
Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation studyAngela McLaughlin, Junine Toy, Vincent Montoya, et al.
The International Journal on Drug Policy|December 30, 2018
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antiviralsRoy Nitulescu, Jim Young, Sahar Saeed, et al.
BMC Public Health|June 13, 2023
Disjuncture between self-perceived and clinically assessed risk of HIV among gay, bisexual, and other men who have sex with men in Ontario and British Columbia, CanadaOscar Javier Pico-Espinosa, Mark Hull, Mark Gaspar, et al.
Lancet Regional Health. Americas|April 9, 2024
Impact of screening and doxycycline prevention on the syphilis epidemic among men who have sex with men in British Columbia: a mathematical modelling studyJielin Zhu, Bronhilda T Takeh, Jummy David, et al.
Pageof 13